T2 Biosystems, Inc. 8-K Filing Insights - February 10, 2025
Based on the provided section of the financial report, here are the key points extracted:
- Entity Information:
- Company Name: T2 Biosystems, Inc.
- CIK (Central Index Key): 0001492674
- IRS Employer Identification Number: 20-4827488
- Address: 101 Hartwell Avenue, Lexington, MA 02421
- Phone Number: (781) 761-4646
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: February 10, 2025
- Stock Exchange: NASDAQ
- Ticker Symbol: TTOO
- Stock Information:
- Common Stock Par Value: $0.001 per share
- Reporting Period:
- Period Covered: February 10, 2025 (the start and end date are the same, indicating this report may cover a specific event or announcement on this date).
Insights:
- The filing indicates that T2 Biosystems, Inc. is publicly traded on NASDAQ under the ticker TTOO, which is relevant for investors and analysts monitoring the company's stock performance.
- The 8-K filing suggests that the company is communicating significant events or changes, which is crucial for stakeholders.
- The par value of the common stock, while not directly indicative of the company's market value, may be relevant in discussions of capital structure and shareholder equity.
Overall, this report appears to be a standard 8-K filing, which typically contains important updates such as changes in management, financial results, or other significant corporate events.